暨南大学药学院学术报告

 题 目：The influence of global regulatory aspects on CMM in R&D of TCM products
报告人：陈金泉教授
单 位：澳大利亚悉尼大学
时 间：2014年5月5日下午15:00
地 点：药学院224会议室
 
陈金泉教授简介
Professor Chan has taken the Joint Chair at Herbal Research & Education Centre (Faculty of Pharmacy) in University of Sydney and Centre for Complementary Medicine Research (College of Health & Science) in University of Western Sydney since 2009.
His passion towards evidence-based approach on TCM research together with his combined expertise and specialty in biomedicine and TCM have equipped him to take a very active role the EU-funded project on “Good Practice of TCM Research in the Post-Genomic Era” from 2009 to 2012. He is the beneficiary member of the Work-package 1 on “Quality of Chinese herbal medicines” and Work-package 3 on “Functional Genomics of the Toxicology of Chinese herbal medicines” and Coordinator of Work-Package 7 on Functional Genomics in the R&D of Chinese herbal medicines”. Hi is also the Co-Chair in the SOP Panel in the Consortium of GPTCM Research. Since taken up the Joint Chair position in 2009 he has become the member of the Advisory Committee for the Centre of Excellence (COE) for Integrative Medicine in Sydney established jointly by the China State Administration of TCM and NSW Government in Australia.
Of the over 600 publications of books/book-chapters/conference presentations/ keynotes, Professor Chan has published over 220 peer-reviewed full papers. His recent directions and interests have since focused towards R&D of Chinese medicines and natural products using technology developed from systems biology, as well as Evidence-Based Medicine in TCM practice.
    欢迎各位老师、同学参加！
          药学院

作者：吉念宁